184 related articles for article (PubMed ID: 17541762)
1. Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia.
Kwon DH; Desai MY
Int J Cardiovasc Imaging; 2008 Jan; 24(1):85-7. PubMed ID: 17541762
[No Abstract] [Full Text] [Related]
2. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
[TBL] [Abstract][Full Text] [Related]
3. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
[No Abstract] [Full Text] [Related]
4. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.
Kwon DH; Setser RM; Popović ZB; Thamilarasan M; Sola S; Schoenhagen P; Garcia MJ; Flamm SD; Lever HM; Desai MY
Int J Cardiovasc Imaging; 2008 Aug; 24(6):617-25. PubMed ID: 18204915
[TBL] [Abstract][Full Text] [Related]
5. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
Appelbaum E; Maron BJ; Adabag S; Hauser TH; Lesser JR; Haas TS; Riley AB; Harrigan CJ; Delling FN; Udelson JE; Gibson CM; Manning WJ; Maron MS
Circ Cardiovasc Imaging; 2012 Jan; 5(1):78-85. PubMed ID: 22135401
[TBL] [Abstract][Full Text] [Related]
6. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
[TBL] [Abstract][Full Text] [Related]
7. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
[TBL] [Abstract][Full Text] [Related]
8. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?
Kim RJ; Judd RM
J Am Coll Cardiol; 2003 May; 41(9):1568-72. PubMed ID: 12742299
[No Abstract] [Full Text] [Related]
10. Aborted sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Casey SA; Almquist AK
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):263. PubMed ID: 10090231
[No Abstract] [Full Text] [Related]
11. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
Teraoka K
Magn Reson Imaging; 2005 Jun; 23(5):701. PubMed ID: 16051047
[No Abstract] [Full Text] [Related]
12. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
Dimitrow PP
Magn Reson Imaging; 2004 Nov; 22(9):1339. PubMed ID: 15607110
[No Abstract] [Full Text] [Related]
13. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
[TBL] [Abstract][Full Text] [Related]
14. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.
Moon JC; McKenna WJ; McCrohon JA; Elliott PM; Smith GC; Pennell DJ
J Am Coll Cardiol; 2003 May; 41(9):1561-7. PubMed ID: 12742298
[TBL] [Abstract][Full Text] [Related]
15. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.
Mavrogeni S; Petrou E; Kolovou G; Theodorakis G; Iliodromitis E
Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):518-25. PubMed ID: 23324829
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.
Frenneaux MP
Heart; 2004 May; 90(5):570-5. PubMed ID: 15084566
[No Abstract] [Full Text] [Related]
17. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
18. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA
Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450
[TBL] [Abstract][Full Text] [Related]
19. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
20. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.
Buja G; Miorelli M; Turrini P; Melacini P; Nava A
Am J Cardiol; 1993 Oct; 72(12):973-6. PubMed ID: 8213559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
